Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 12-2022 | 12-2021 | 06-2021 | |
| Operating Expenses | 7,310 | 11,114 | 1,570 | 249 | 249 |
| Operating Income | -7,310 | -11,114 | -1,570 | -249 | -249 |
| Other Income | 0 | 0 | 654 | 1 | 0 |
| Pre-tax Income | -7,310 | -11,114 | -916 | -248 | -249 |
| Income Tax | 2 | N/A | 81 | N/A | 0 |
| Net Income Continuous | -7,312 | -11,114 | -996 | -248 | -249 |
| Net Income | $-7,312 | $-11,114 | $-996 | $-248 | $-248 |
| EPS Basic Total Ops | -0.27 | -36.35 | -0.22 | -1.52 | N/A |
| EPS Basic Continuous Ops | -0.27 | -36.35 | -0.70 | -0.21 | N/A |
| EPS Diluted Total Ops | -0.27 | -36.35 | -0.22 | -1.52 | N/A |
| EPS Diluted Continuous Ops | -0.27 | -36.35 | -0.70 | -0.21 | N/A |
| EBITDA(a) | $-7,310 | $-11,114 | $-1,570 | $-249 | $-249 |